We previously reported that trisomy 21 (T21) fetuses have an intrinsic lipi
d metabolism abnormality resulting in higher serum cholesterol levels than
their matched controls. In an attempt to clarify the biochemical basis of t
his derangement we analyzed the liver cholesterol levels and activation of
the sterol regulatory element binding proteins SREBP-1 and SREBP-2. We repo
rt here for the first time that SREBP-1 and SREBP-2 are present in human fe
tal liver and their activation follows a different regulatory pattern. More
over T21 fetuses show a peculiar pattern of SREBP activation which, at vari
ance from control fetuses, involves sterol-independent maturation of SREBP-
1. Multiple defects accompanied the lipid derangement in T21, resulting in
high circulating and tissue cholesterol. This may serve as an early biochem
ical marker of an unknown, possibly genetically determined mechanism, whose
consequence on lipid homeostasis during postnatal and adult life is still
not understood. (C) 1999 Academic Press.